Categories: Health

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 | Source: Chimerix, Inc.

DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), today announced that on January 17, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to six new employees of non-statutory stock options to purchase up to a total of 355,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4).

The stock options have an exercise price per share equal to Chimerix’s closing trading price as of the grant date. The stock options have a 10-year term and will vest over four years, with one-fourth vesting on the one-year anniversary of the date of hire and the remaining three-fourths vesting over the following three years in equal monthly installments. The stock options are subject to the terms of Chimerix’s 2024 Equity Incentive Plan but were granted outside of the 2024 Equity Incentive Plan.

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, dordaviprone (ONC201), is in development for H3 K27M-mutant glioma. The Company is conducting Phase 1 dose escalation studies of ONC206 to evaluate safety and PK data.

CONTACTS:

Will O’Connor
Stern Investor Relations
212-362-1200
ir@chimerix.com
will@sternir.com

GlobeNews Wire

Recent Posts

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

May 23, 2025 16:15 ET  | Source: Plus Therapeutics Inc. HOUSTON, May 23, 2025 (GLOBE…

7 hours ago

Polyrizon Announces Receipt of Nasdaq Delisting Notice

May 23, 2025 16:15 ET  | Source: Polyrizon Ltd. Raanana, Israel, May 23, 2025 (GLOBE…

7 hours ago

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

May 23, 2025 16:05 ET  | Source: PMV Pharmaceuticals, Inc. PRINCETON, N.J., May 23, 2025…

7 hours ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

May 23, 2025 16:05 ET  | Source: AEON Biopharma IRVINE, Calif., May 23, 2025 (GLOBE…

7 hours ago

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the…

7 hours ago

The world says ‘NamAIste’ to Made in India’s world’s first Hospitality GPT by IIHM

AI-powered knowledge engine built on deep domain research is the global hospitality industry's biggest innovation.…

7 hours ago